Literature DB >> 24569080

microRNA-222 modulates liver fibrosis in a murine model of biliary atresia.

Wen-jun Shen1, Rui Dong1, Gong Chen2, Shan Zheng1.   

Abstract

microRNA-222 (miR-222) has been shown to initiate the activation of hepatic stellate cells, which plays an important role in the pathogenesis of liver fibrosis. The aim of our study was to evaluate the role of miR-22 in a mouse model of biliary atresia (BA) induced by Rhesus Rotavirus (RRV) infection. New-born Balb/c mice were randomized into control and RRV infected groups. The extrahepatic bile ducts were evaluated. The experimental group was divided into BA group and negative group based on histology. The expression of miR-222, protein phosphatase 2 regulatory subunit B alpha (PPP2R2A), proliferating cell nuclear antigen (PCNA) and phospho-Akt were detected. We found that the experimental group showed signs of cholestasis, retardation and extrahepatic biliary atresia. No abnormalities were found in the control group. In the BA group, miR-222, PCNA and Akt were highly expressed, and PPP2R2A expression was significantly inhibited. Our findings suggest that miR-222 profoundly modulated the process of fibrosis in the murine BA model, which might represent a potential target for improving BA prognosis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biliary atresia; Liver fibrosis; Murine model; microRNA

Mesh:

Substances:

Year:  2014        PMID: 24569080     DOI: 10.1016/j.bbrc.2014.02.065

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Delivery and targeting of miRNAs for treating liver fibrosis.

Authors:  Virender Kumar; Ram I Mahato
Journal:  Pharm Res       Date:  2014-09-04       Impact factor: 4.200

2.  Expression Profile Analysis of miR-221 and miR-222 in Different Tissues and Head Kidney Cells of Cynoglossus semilaevis, Following Pathogen Infection.

Authors:  Hui Yan; Yadong Chen; Shun Zhou; Chao Li; Guangye Gong; Xuejie Chen; Tianzi Wang; Songlin Chen; Zhenxia Sha
Journal:  Mar Biotechnol (NY)       Date:  2015-09-29       Impact factor: 3.619

Review 3.  The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis.

Authors:  Sanchari Roy; Fabian Benz; Tom Luedde; Christoph Roderburg
Journal:  Hepatobiliary Surg Nutr       Date:  2015-02       Impact factor: 7.293

4.  MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression.

Authors:  Bo Tang; Biao Lei; Guangying Qi; Xingsi Liang; Fang Tang; Shengguang Yuan; Zhenran Wang; Shuiping Yu; Songqing He
Journal:  J Exp Clin Cancer Res       Date:  2016-06-16

5.  Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia.

Authors:  Rui Dong; Zhen Shen; Chao Zheng; Gong Chen; Shan Zheng
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

Review 6.  Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.

Authors:  Chong-Yang Zhang; Wei-Gang Yuan; Pei He; Jia-Hui Lei; Chun-Xu Wang
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

Review 7.  Function and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver Disease.

Authors:  Diego A Calvopina; Miranda A Coleman; Peter J Lewindon; Grant A Ramm
Journal:  Int J Mol Sci       Date:  2016-10-27       Impact factor: 5.923

8.  Targeting hepatic miR-221/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice.

Authors:  Xiuli Jiang; Lei Jiang; Aijing Shan; Yutong Su; Yulong Cheng; Dalong Song; He Ji; Guang Ning; Weiqing Wang; Yanan Cao
Journal:  EBioMedicine       Date:  2018-10-10       Impact factor: 8.143

9.  miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells.

Authors:  Li-Ping Zeng; Zheng-Mao Hu; Kai Li; Kun Xia
Journal:  J Cell Mol Med       Date:  2016-01-22       Impact factor: 5.310

10.  RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection.

Authors:  L N L Van Aelst; G Summer; S Li; S K Gupta; W Heggermont; K De Vusser; P Carai; M Naesens; J Van Cleemput; F Van de Werf; J Vanhaecke; T Thum; M Waer; A-P Papageorgiou; B Schroen; S Heymans
Journal:  Am J Transplant       Date:  2015-08-06       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.